Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 3.85
-2.78 %
$ 211 M
Market Cap
-8.19
P/E
1. INTRINSIC VALUE
Balance Sheet
Aurora Cannabis Inc.
| Current Assets | 427 M |
| Cash & Short-Term Investments | 117 M |
| Receivables | 45.4 M |
| Other Current Assets | 264 M |
| Non-Current Assets | 412 M |
| Long-Term Investments | 6.34 M |
| PP&E | 294 M |
| Other Non-Current Assets | 111 M |
| Current Liabilities | 125 M |
| Accounts Payable | 20.3 M |
| Short-Term Debt | 57.2 M |
| Other Current Liabilities | 47.1 M |
| Non-Current Liabilities | 112 M |
| Long-Term Debt | 47.6 M |
| Other Non-Current Liabilities | 64.6 M |
EFFICIENCY
Earnings Waterfall
Aurora Cannabis Inc.
| Revenue | 270 M |
| Cost Of Revenue | 139 M |
| Gross Profit | 131 M |
| Operating Expenses | 159 M |
| Operating Income | -46.5 M |
| Other Expenses | 12.6 M |
| Net Income | -59 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Aurora Cannabis Inc.
| Net Income | -59 M |
| Depreciation & Amortization | 33.1 M |
| Capital Expenditures | -17 M |
| Stock-Based Compensation | 12.7 M |
| Change in Working Capital | -15.6 M |
| Others | -70.7 M |
| Free Cash Flow | -85.5 M |
Wall Street Analysts Price Targets
Aurora Cannabis Inc.
Wall Street analysts predict an average 1-year price target for ACB of $6.67 , with forecasts ranging from
a
low of
$1 to a high of $11 .
ACB Lowest Price Target
Wall Street Target
1 USD
-74.03%
ACB Average Price Target
Wall Street Target
6.67 USD
73.16%
ACB Highest Price Target
Wall Street Target
11 USD
185.71%
4. DIVIDEND
ANALYSIS
ACB does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Aurora Cannabis Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|
7. News
2025 Outlook: The Best Canadian Cannabis Stocks to Watch Now
The cannabis industry continues to evolve rapidly, presenting unique investment opportunities, especially in Canadian cannabis stocks. With the U.S. cannabis market projected to exceed $40 billion by 2025, legalization efforts are gaining traction. Recent news highlights growing bipartisan support for federal cannabis reform in the U.S., which could further boost industry expansion. Canadian cannabis companies, with their well-established infrastructure and international presence, are strategically positioned to capitalize on this growth. Tracking key stocks with solid fundamentals and technical setups becomes essential as investors look for potential gains.
marijuanastocks.com
- 3 weeks ago
Better Marijuana Stock: Aurora Cannabis or Tilray Brands?
The global cannabis market tells a tale of survival and adaptation. After a brutal multiyear shakeout that saw dozens of companies fold or merge, the remaining players have emerged battle-tested and strategically transformed.
fool.com
- 1 month ago
Aurora Announces Distribution Partnership Between MedReleaf Australia and The Entourage Effect
NASDAQ | TSX: ACB The collaboration aims to broaden access of premium medical cannabis products to Australian patients EDMONTON, AB , Dec. 17, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce a distribution partnership between The Entourage Effect and MedReleaf Australia. The Entourage Effect provides comprehensive distribution and support services to pharmacies in Australia and will serve as a wholesaler for MedReleaf Australia's leading portfolio of products under the CraftPlant, Aurora, and IndiMed brands, furthering the mission to expand access for Australian patients.
prnewswire.com
- 1 month ago
Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities
Cannabis stocks have faced significant challenges recently, driven by political uncertainty that has further weighed on a sector still struggling to regain its footing since the overhyped all-time highs of 2021.
benzinga.com
- 1 month ago
Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility
NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company Continues to Offer Greater Choice for Patients EDMONTON, AB , Nov. 26, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces developments in cannabis science from Aurora's world class research and genetics facility, Aurora Coast. With a continued focus on premium, science-driven insights, these latest innovations demonstrate Aurora's commitment to providing patients with ongoing access to superior product offerings on AuroraMedical.com.
prnewswire.com
- 1 month ago
Aurora Cannabis Expands Innovative Recreational Product Portfolio
NASDAQ | TSX: ACB Introduces New Products and Flavours across Greybeard, San Rafael '71 and Tasty's brands EDMONTON, AB , Nov. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is excited to announce its latest lineup of innovations from Greybeard, San Rafael '71 and Tasty's brands. With a continued focus on premium, science-driven offerings, this expanded lineup represents Aurora's commitment to delivering exceptional high quality, cutting-edge and diverse options for Canadian cannabis consumers.
prnewswire.com
- 1 month ago
Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy +
The 'Undercovered' Dozen series highlights 12 lesser-covered stocks from the past week, aiming to spark ideas and discussions among retail investors. Veradigm Inc. is undervalued due to regulatory pressures, but has significant upside potential with strategic buyers potentially paying mid- or high-teens per share. Casey's General Stores has outperformed its peers and the S&P 500 due to its strategic positioning in rural areas and strong operational execution.
seekingalpha.com
- 2 months ago
3 Marijuana Stocks For Today Watchlist
The future of cannabis investing rests in the hands of politicians who may not have the industry's best interests at heart. Right now, the majority of marijuana stocks are feeling the impact of cannabis politics surrounding reform and regulatory issues. Each party, Republicans and Democrats, walks a different path to passing comprehensive reform and looking at the sector as a whole.
marijuanastocks.com
- 2 months ago
Aurora Cannabis: Buy The Election Overreaction
Aurora Cannabis dropped over 10%, along with the broader cannabis market, due to concerns over U.S. election results. Despite this, Aurora has no U.S. cannabis operations and is unaffected. Aurora reported robust revenue growth, with a 29% YoY increase, driven by a 93% rise in international medical cannabis sales. The company re-affirmed positive free cash flow expectations for Q3 and demonstrated strong spending discipline, maintaining positive adjusted EBITDA for the 8th consecutive quarter.
seekingalpha.com
- 2 months ago
Cannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalization
Amendment 3 – which would have legalized the recreational use of marijuana in the state's constitution – failed to receive the 60% support needed to pass under Florida law.
nypost.com
- 2 months ago
Aurora Cannabis Inc. (ACB) Beats Q2 Earnings and Revenue Estimates
Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.22 per share. This compares to loss of $0.50 per share a year ago.
zacks.com
- 2 months ago
Cannabis stocks tank as Florida votes against recreational marijuana
Shares in cannabis stocks such as Trulieve Cannabis Corp. (CSE:TRUL), Curaleaf Hldgs Inc. (CSE:CURA, OTCQX:CURLF) and Verano Holdings Corp (CSE:VRNO, OTCQX:VRNOF) tanked after Florida rejected legalization of recreational marijuana. A ballot measure, known as Amendment 3, which would have allowed adults to possess up to three ounces of marijuana, failed to obtain the required 60% of support from voters yesterday.
proactiveinvestors.com
- 2 months ago
8. Profile
Summary
Aurora Cannabis Inc. ACB
COUNTRY
CA
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 211 M
Dividend Yield
0.00%
Description
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Contact
500 - 10355 Jasper Avenue, Edmonton, AB, T5J 1Y6
https://www.auroramj.com
IPO
Date
July 15, 2014
Employees
1073
Officers
Mr. Andre Jerome
Executive Vice President of Global Business Development
Mr. Ananth Krishnan
Vice President of Capital Markets & Investor Relations
Mr. Miguel Martin
Chief Executive Officer & Executive Chairman
Michelle Lefler
Vice President of Communications & Public Relations
Mr. Rick Savone
Senior Vice President of Global Government Relations
Mr. Alex Miller
Executive Vice President of Operations & Supply Chain
Ms. Nathalie Clark
Executive Vice President, General Counsel & Corporate Secretary
Dr. Jonathan Page Ph.D.
Senior Science Advisor
Ms. Simona King CPA
Chief Financial Officer
Ms. Lori Schick
Executive Vice President of Human Resources